HTS
High Throughput Screening Market to Hit $19 Billion by 2018
March 12 by Gerald ClarkeHigh Throughput Screening is growing rapidly as it becomes essential for new sectors and old areas find new applications for it. According to a new report titled High Throughput Screening (HTS) Mark...
Stem Cells; the Future of Drug Development?
September 06 by Gerald ClarkeStem cells have been in the media for years now as the most promising therapeutic intervention, but their medical promise may be broader than as treatments themselves. Stem cells can be used as cell...
High-Throughput Screening: Best Practice, Trends and Challenges
March 07 by Pharma IQHigh-throughput screening (HTS) has developed into a hugely important and valuable area for the pharmaceutical industry, particularly in the field of drug discovery. The method has the potential...
Expanding Sample Libraries Tops the Wish List for Compound and Sample Managers
May 21 by Pharma IQSuccessful drug discovery depends on having efficient compound management systems in place, which means access to a growing library of high quality compounds and samples, and sufficient automation t...
Integrating Compound Management, Analytical and Automation Workflows to Contribute to Drug Discovery Success
February 07 by Pharma IQNew and novel compounds lie at the heart of the drug discovery process. So much so, that drug discovery materials management has emerged as a discipline within itself. The pharmaceutical industry...
Reflections on Compound Management in an Ever-Changing Organisation
September 16 by Pharmaceuticals & Biotechnology EditorTenna Juul Schroder, Head of Department, Molecular Pharmacology, Lundbeck, shares her insights on compound management in an ever-changing organisation and discusses new compound management strategie...
How to Profit from Compound Management Know-How?
September 14 by Pharmaceuticals & Biotechnology EditorOliver Peter, PhD, Group Head of Drug Discovery Biology at HTS Group, Actelion Pharmaceuticals, joins Pharma IQ, to discuss compounds and biosamples and materials management.In this interview&n...
GlaxoSmithKline, Johnson & Johnson, Pfizer, AstraZeneca and More Present at the 6th Compound Management & Integrity Conference in Philadelphia, PA
August 26 by Pharma IQ NewsAn efficient and versatile compound management operation is essential for the success of all downstream processes in high throughput screening (HTS) and small molecule development. The 6th Comp...
High Throughput Screening Lessons Learnt: How Biobanking Can Benefit?
July 19 by Pharma IQMark Divers is the head of the Karolinska Institute’s biobank project in Sweden. He talks us through some of the key concerns before his seminar at this year’s conference. To listen to t...
Re-sculpting the Pfizer Screening File
July 15 by Pharma IQDr. Andy Bell, Research Fellow at Sandwich Laboratories Worldwide R&D, Pfizer, shares his insights on Pfizer's review of their screening file, prior to the merger with Wy...
Automation Considerations for RNAi Library Formatting and High Throughput Transfection
April 27 by Sean JohnstonThe ICCB-Longwood Screening Facility at Harvard Medical School is a resource for academic investigators carrying out small molecule and genome-wide siRNA screens. When they began supporting siRNA sc...